T 0883/23 (Liposomal irinotecan drug combination/IPSEN) du 26.09.2025
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2025:T088323.20250926
- Date de la décision
- 26 septembre 2025
- Numéro de l'affaire
- T 0883/23
- Requête en révision de
- -
- Numéro de la demande
- 16758337.6
- Classe de la CIB
- A61P 35/04A61K 31/519A61K 31/282A61K 31/4745A61K 31/436A61K 31/513A61K 9/127A61K 31/475
- Langue de la procédure
- Anglais
- Distribution
- Distribuées aux présidents des chambres de recours (C)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- Résumé de Article 087(1) EPCRésumé de Article 12(6) RPBA
- Titre de la demande
- DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER
- Nom du demandeur
- Ipsen Biopharm Ltd.
- Nom de l'opposant
- Sandoz AG
Generics [UK] Limit - Chambre
- 3.3.07
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 56European Patent Convention Art 87(1)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Mots-clés
- Priority - same invention (no)
Late-filed evidence - should have been submitted in first-instance proceedings (yes)
Late-filed evidence - circumstances of appeal case justify admittance (no)
Inventive step - (yes) - Exergue
- The Enlarged Board of Appeal determined in G 2/98 that it is a condition for the compliance with the requirement of "the same invention" that the claimed subject-matter is directly and unambiguously derivable from the earlier application. However, the Enlarged Board did not conclude that the requirement of "the same invention" is necessarily satisfied if this condition is fulfilled, irrespective of any technical information associated with the claimed subject-matter, which is only described in the subsequent patent application.
(see point 1.5 of the decision) - Affaires citantes
- -
Order
For these reasons it is decided that:
The appeals are dismissed.